JUPITER NEUROSCIENCES, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- JUPITER NEUROSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $212.61K.
- JUPITER NEUROSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $66.00K, a 12.00% decline year-over-year.
- JUPITER NEUROSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2024-12-31 was $75.00K.
- JUPITER NEUROSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $75.00K.
- JUPITER NEUROSCIENCES, INC. stock issued during period, value, new issues for fiscal 2024 was $150.00K, a 172.73% increase from fiscal 2023.
- JUPITER NEUROSCIENCES, INC. stock issued during period, value, new issues for fiscal 2023 was $55.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-09-30 | $212.61K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $66.00K 10-Q · filed 2025-08-19 | |
| 2024-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $150.00K 10-K · filed 2026-04-01 |
| 2024-06-30 | $75.00K 10-Q · filed 2025-08-19 | |
| 2023-12-31 | $55.00K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |